Similar Items: Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications
- Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021
- Correction to “Disease Burden of Liver Cancer and Its Underlying Etiologies Globally and in China From 1990 to 2021: Results From the Global Burden of Disease Study 2021”
- NADPH Oxidases in Chronic Liver Diseases
- Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease
- Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease
- Data-Driven Healthy China Pathway: Evolution, Framework, and Global Implications of National Digital Health Strategic Planning